Sanket Joshi
Sanket holds PhD in cancer cell biology from the University of Sydney followed by five years’ post-doctoral experience at Cancer Research UK - Beatson Institute and UNSW, Australia. During this time, he researched on characterising novel therapeutic targets within the areas of cell division cycle, immuno-oncology and cancer metabolism. Sanket has first and co-authored peer-reviewed articles in high impact scientific journals such as Molecular Cancer Therapeutics, Nature Cell Biology, PNAS USA and Cell. Following his post-doctoral studies, Sanket worked in a client-facing role at the ACRF Drug Discovery Centre (CCIA) where he delivered fee-for-service projects for academics, clinicians and biotech companies. Sanket joined the In Vitro team in November 2018 as a Life Science Territory Manager for NSW and ACT. Sanket developed his skills exceptionally well and was promoted to Product Manager from July 2019 for company’s Cancer Biology and Cell & Gene Therapy portfolio.
Abstracts this author is presenting:
